跳至主要内容
临床试验/NCT00856765
NCT00856765已完成2 期

Randomized Comparison of Drug Eluting Balloon/Bare Metal Stent Versus Drug Eluting Stent Versus Bare Metal Stent for the Treatment of Patients With Acute ST-elevation Myocardial Infarction

UMC Utrecht3 个研究点 分布在 2 个国家目标入组 150 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
UMC Utrecht
入组人数
150
试验地点
3
主要终点
Angiographic in-segment late lumen loss (expressed in millimeters) as determined by quantitative coronary analysis (QCA)

研究概览

简要总结

The investigators hypothesize that patients with Acute ST Elevation Myocardial Infarction may benefit from primary angioplasty with use of a drug eluting balloon/bare metal stent combination without impairing the process of normal vascular healing and endothelial function.

The goals of this study are:

  1. To compare 6-month angiographic outcome after primary angioplasty using drug eluting balloon/bare metal stent combination versus drug eluting stent versus bare metal stent.
  2. To compare stent apposition and stent endothelialization after primary angioplasty using drug eluting balloon/bare metal stent versus drug eluting stent versus bare metal stent.
  3. To compare coronary endothelial function after primary angioplasty using drug eluting balloon/bare metal stent versus drug eluting stent versus bare metal stent.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • STEMI within 12 hours of onset of complaints
  • Candidate for primary PCI with stent-implantation
  • Successful thrombus aspiration defined by no angiographic signs of thrombus a the site of plaque rupture and TIMI flow more or equal 1

排除标准

  • Unable to give written informed consent
  • Diabetes and Type C- coronary lesion
  • Previous PCI or CABG of infarct related vessel
  • Left main stenosis more than 50%.
  • Triple vessel disease with stenosis more than 50% in 3 epicardial coronary arteries
  • Target vessel reference diameter less than 2.5 and more than 4.0 mm
  • Target lesion length more than 25 mm
  • Intolerance for aspirin or clopidogrel
  • Life expectancy less than 12 months
  • Women with child bearing potential

结局指标

主要结局

Angiographic in-segment late lumen loss (expressed in millimeters) as determined by quantitative coronary analysis (QCA)

时间窗: 6 months

次要结局

  • stent malapposition and re-endothelialization assessed by Optical Coherence Tomography (OCY)(6 months)
  • coronary endothelial dysfunction after acetylcholine infusion(6 months)
  • Clinical outcomes (death, myocardial infarction, repeated revascularization procedures)(5 years)
  • Binary restenosis using QCA(6 months)

研究者

发起方
UMC Utrecht
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Pieter Stella

PHD.MD

UMC Utrecht

研究点 (3)

Loading locations...

相似试验